Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Public ClinicalTrials.gov record NCT02863809. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase I/II prospective, randomized, multi-center, double-masked, vehicle-controlled clinical trial evaluating the safety and efficacy of corneal collagen cross-linking the keratoprosthesis carrier tissue in subjects who are candidates for high-risk keratoprosthesis implantation but because of a history of corneal melts or autoimmune diseases are not candidate for a traditional corneal transplant.
Study identification
- NCT ID
- NCT02863809
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 76 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2017
- Primary completion
- Jun 29, 2021
- Completion
- Aug 30, 2021
- Last update posted
- May 9, 2023
2017 – 2021
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Jules Stein Eye Institute | Los Angeles | California | 90095-7003 | — |
| UC Davis Health System Eye Center | Sacramento | California | 95817 | — |
| Shiley Eye Institute, University of California, San Diego | San Diego | California | 92093 | — |
| Bascom Palmer eye Institute | Miami | Florida | 33136 | — |
| Illinois Eye and Ear Infirmary | Chicago | Illinois | 60612 | — |
| Cincinnati Eye Institute | Edgewood | Kentucky | 41017 | — |
| Wilmer Eye Institute | Baltimore | Maryland | 21287 | — |
| W.K. Kellogg Eye Center | Ann Arbor | Michigan | 48105 | — |
| Tauber Eye Center | Kansas City | Missouri | 64111 | — |
| David and Ilene Flaum Eye Institute, University of Rochester | New York | New York | 14642 | — |
| University Hospitals Eye Institute | Cleveland | Ohio | 44106 | — |
| Wills Eye | Bala-Cynwyd | Pennsylvania | 19007 | — |
| Wilford Hall Ambulatory Surgical Center (WHASC) | Lackland Air Force Base | Texas | 78236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02863809, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2023 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02863809 live on ClinicalTrials.gov.